3.119 Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11 C-raclopride PET study
โ Scribed by M. Politis; P. Piccini; N. Pavese; S.-B. Koh; D.J. Brooks
- Book ID
- 117753067
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 59 KB
- Volume
- 13
- Category
- Article
- ISSN
- 1353-8020
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Increasing evidence suggests that neuroinflammation is an active process in Parkinson's disease (PD) that contributes to ongoing neurodegeneration. PD brains and experimental PD models show elevated cytokine levels and upโregulation of inflammatoryโassociated factors as cycloโoxygenaseโ
## Abstract We used [^11^C]raclopride (RACLO) and positron emission tomography (PET) to study longitudinally striatal dopamine D~2~ receptor binding in nine patients with Parkinson's disease (PD) at an early drugโnaive stage and 3โ5 years later, when motor fluctuations had appeared in seven of them